Anti-PKHD1 monoclonal antibody

Pre-made anti-PKHD1 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to PKHD1/PKHD1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP1406-Ab-1/ GM-Tg-hg-IP1406-Ab-2Anti-Human PKHD1 monoclonal antibodyHuman
GM-Tg-rg-IP1406-Ab-1/ GM-Tg-rg-IP1406-Ab-2Anti-Rat PKHD1 monoclonal antibodyRat
GM-Tg-mg-IP1406-Ab-1/ GM-Tg-mg-IP1406-Ab-2Anti-Mouse PKHD1 monoclonal antibodyMouse
GM-Tg-cynog-IP1406-Ab-1/ GM-Tg-cynog-IP1406-Ab-2Anti-Cynomolgus/ Rhesus macaque PKHD1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP1406-Ab-1/ GM-Tg-felg-IP1406-Ab-2Anti-Feline PKHD1 monoclonal antibodyFeline
GM-Tg-cang-IP1406-Ab-1/ GM-Tg-cang-IP1406-Ab-2Anti-Canine PKHD1 monoclonal antibodyCanine
GM-Tg-bovg-IP1406-Ab-1/ GM-Tg-bovg-IP1406-Ab-2Anti-Bovine PKHD1 monoclonal antibodyBovine
GM-Tg-equg-IP1406-Ab-1/ GM-Tg-equg-IP1406-Ab-2Anti-Equine PKHD1 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP1406-Ab-1/ GM-Tg-hg-IP1406-Ab-2; GM-Tg-rg-IP1406-Ab-1/ GM-Tg-rg-IP1406-Ab-2;
GM-Tg-mg-IP1406-Ab-1/ GM-Tg-mg-IP1406-Ab-2; GM-Tg-cynog-IP1406-Ab-1/ GM-Tg-cynog-IP1406-Ab-2;
GM-Tg-felg-IP1406-Ab-1/ GM-Tg-felg-IP1406-Ab-2; GM-Tg-cang-IP1406-Ab-1/ GM-Tg-cang-IP1406-Ab-2;
GM-Tg-bovg-IP1406-Ab-1/ GM-Tg-bovg-IP1406-Ab-2; GM-Tg-equg-IP1406-Ab-1/ GM-Tg-equg-IP1406-Ab-2
Products NameAnti-PKHD1 monoclonal antibody
Formatmab
Target NamePKHD1
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-PKHD1 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP1406-Ag-1Recombinant multi-species PKHD1/ ARPKD/ FCYT protein


    Target information

    Target IDGM-IP1406
    Target NamePKHD1
    Gene ID5314,241035,301287,710087,474934,101095100,537895,100069045
    Gene Symbol and SynonymsAABR07067023.1,ARPKD,FCYT,FPC,PKD4,PKHD1,TIGM1
    Uniprot AccessionP08F94,E2RK30
    Uniprot Entry NamePKHD1_HUMAN,PKHD1_CANLF
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000170927
    Target ClassificationN/A

    The target: PKHD1, gene name: PKHD1, also named as ARPKD, FCYT, FPC, PKD4, TIGM1. The protein encoded by this gene is predicted to have a single transmembrane (™)-spanning domain and multiple copies of an immunoglobulin-like plexin-transcription-factor domain. Alternative splicing results in two transcript variants encoding different isoforms. Other alternatively spliced transcripts have been described, but the full length sequences have not been determined. Several of these transcripts are predicted to encode truncated products which lack the ™ and may be secreted. Mutations in this gene cause autosomal recessive polycystic kidney disease, also known as polycystic kidney and hepatic disease-1. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.